AI-Powered News AnalysisCompare coverage across the political spectrum

#biotech

Related Stories (8)

Vertex to buy Crinetics for $10 billion in rare-diseases push - Reuters

Vertex to buy Crinetics for $10 billion in rare-diseases push Reuters

July 6, 2026

Abivax nears $11 billion valuation after fundraising eases M&A pressure - Reuters

Abivax nears $11 billion valuation after fundraising eases M&A pressure Reuters

July 1, 2026

French biotech company Ipsen to buy Kartos Therapeutics for $450 million - Reuters

French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters

June 29, 2026

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push - Reuters

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Reuters

June 22, 2026

Heart drug developer Kardigan targets $1.4 billion valuation in US IPO - Reuters

Heart drug developer Kardigan targets $1.4 billion valuation in US IPO Reuters

June 11, 2026

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say - Reuters

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say Reuters

April 22, 2026

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters

March 25, 2026

Henrietta Lacks: Family of woman whose cells were 'stolen' settles second lawsuit

Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.

February 28, 2026